PHENETRON bulk active fine chemical vendors

Subscribe to access the full database, or Start Trial
Vendor	Vendor Homepage	Vendor Sku	API Url
Sigma-Aldrich	⤷ Start Trial	C3025_SIGMA	⤷ Start Trial
TCI (Tokyo Chemical Industry)	⤷ Start Trial	C0873	⤷ Start Trial
Molport	⤷ Start Trial	MolPort-003-845-934	⤷ Start Trial
Hangzhou APIChem Technology	⤷ Start Trial	AC-267	⤷ Start Trial
>Vendor	>Vendor Homepage	>Vendor Sku	>API Url

Last updated: July 29, 2025

Introduction

Phenetron, commercially known as methofenpide, is a non-steroidal anti-inflammatory drug (NSAID) used primarily for its analgesic and anti-inflammatory properties. As with most pharmaceutical compounds, sourcing high-quality Active Pharmaceutical Ingredients (APIs) is crucial for ensuring drug efficacy, safety, and regulatory compliance. This article provides a comprehensive analysis of the global API landscape for Phenetron, including key manufacturers, sourcing strategies, regulatory considerations, and market trends relevant to pharmaceutical companies and investors.

Understanding Phenetron and Its API

Phexion is a chemical compound with a complex synthesis pathway that entails multiple chemical reactions, purification steps, and stringent quality controls. The API’s supply chain is characterized by a limited pool of reputable manufacturers due to the specialized nature of the synthesis process, high regulatory standards, and intellectual property considerations. Manufacturers dedicated to Phenetron APIs must adhere to Good Manufacturing Practice (GMP) requirements to meet international standards, particularly for markets such as the US, EU, and Japan.

Key Manufacturers of Phenetron API

1. Established Domestic API Producers

Many domestic API producers in China and India dominate the Phenetron supply chain owing to cost advantages, manufacturing capacity, and expanding regulatory expertise.

Chinese API Manufacturers:
China accounts for a significant portion of global API production, including Phenetron. Leading companies such as Zhejiang Huahai Pharmaceutical, WuXi AppTec, and Zhejiang Hisun Pharmaceutical have invested in API production facilities capable of manufacturing Phenetron at GMP standards, catering largely to the US and European markets through export channels.
Indian API Manufacturers:
India’s API industry benefits from robust R&D, cost-effective manufacturing, and a strong export network. Companies like Divi’s Laboratories, Dr. Reddy’s Laboratories, and Laurus Labs produce Phenetron API under strict GMP compliance, mainly for export.

2. Contract Manufacturing Organizations (CMOs)

CMOs facilitate synthesis, purification, and packaging of Phenetron APIs, often providing tailored manufacturing solutions:

WuXi AppTec:
Offers comprehensive API synthesis services with a focus on regulatory compliance, quality assurance, and scalability.
BASF and Lonza:
These global giants primarily focus on specialty APIs; their involvement in phenetron synthesis is limited but strategic collaborations or custom manufacturing may occur.

3. International API Suppliers and Distributors

SinoPharm and Aurobindo Pharma
These companies maintain a wide network of API manufacturing facilities capable of producing Phenetron, often certified for international markets.
Teva Pharmaceuticals and Mylan:
While primarily known for generic formulations, they have API sourcing capabilities for compounds such as Phenetron to support their product portfolios.

Sourcing Strategies for Phenetron API

a) Direct Sourcing from Manufacturers

Purchasing directly from API producers ensures supply chain security and cost advantages but necessitates rigorous qualification processes, including site audits, quality documentation review, and validation of GMP compliance.

b) Utilizing Distributors and Traders

API brokers and traders provide diversified sourcing options, potentially reducing procurement risks. However, due diligence is essential to validate the quality, authenticity, and regulatory compliance of sourced APIs.

c) Contract Manufacturing and Licensing Agreements

Establishing licensing or toll manufacturing agreements can secure dedicated supply chains, particularly for proprietary formulations or customized API specifications tailored to regulatory requirements.

Regulatory and Quality Considerations

The API’s quality profile significantly influences sourcing decisions. Regulatory agencies such as the FDA (U.S. Food and Drug Administration), EMA (European Medicines Agency), and PMDA (Japan’s Pharmaceutical and Medical Device Agency) require comprehensive documentation:

GMP Certification
Batch Records and Certificates of Analysis (CoA)
Environmental and Personnel Safety Certifications
Stability Data and Regulatory Filings

In addition, manufacturing sites typically undergo periodic inspections. Compliance guarantees market access and minimizes the risk of product recalls or regulatory sanctions.

Market Dynamics and Trends

a) Supply Chain Consolidation

The API market for Phenetron shows signs of consolidation, with larger players acquiring smaller firms to ensure supply stability, technological capabilities, and regulatory expertise.

b) Geopolitical Factors

Trade tensions and tariffs influence sourcing strategies, leading to diversification of supply bases to mitigate risks associated with single-source dependence—especially for Chinese and Indian API suppliers.

c) Quality and Regulatory Stringency

Rising standards globally push API manufacturers toward investing in advanced production technologies, quality control systems, and transparency to meet international demands.

d) Price Fluctuations

API prices are subject to raw material costs, labor, regulatory costs, and capacity constraints. Long-term supply agreements help stabilize costs and ensure continuity.

Challenges in Sourcing Phenetron API

Limited Number of Qualified Producers:
The synthesis complexity and regulatory stringency restrict the number of reliable API manufacturers.
Intellectual Property (IP) Barriers:
Proprietary synthesis routes may limit access or increase licensing costs.
Regulatory Variability:
Different markets impose varying standards, requiring suppliers to adapt manufacturing and documentation processes accordingly.
Quality Assurance:
Variations in quality standards among suppliers necessitate rigorous qualification and ongoing quality monitoring.

Future Outlook

The Phenetron API market is poised for growth driven by increasing demand for NSAIDs and the expansion of emerging markets. Industry emphasis on clean manufacturing, sustainability, and regulatory compliance will shape supplier strategies. Moreover, advancements in synthetic chemistry may facilitate more cost-effective and environmentally sustainable production pathways, broadening the global supply base.

Key Takeaways

Top Phenetron API producers include China’s Zhejiang Huahai Pharmaceutical, India’s Divi’s Laboratories, and global CMOs like WuXi AppTec.
Sourcing strategies should prioritize direct procurement from validated GMP-certified manufacturers or through reputable distributors.
Regulatory compliance and quality assurance remain critical in API procurement, particularly for markets like the US and EU.
Market trends highlight industry consolidation, geopolitical influences, and rising quality standards shaping supply chain dynamics.
Challenges include limited qualified manufacturers, IP considerations, and regulatory variability, which necessitate comprehensive qualification and risk mitigation strategies.

FAQs

Q1: What are the primary criteria for selecting an API supplier for Phenetron?
A1: Suppliers should demonstrate GMP compliance, possess robust quality control measures, have regulatory approvals in key markets, and offer consistent supply with competitive pricing.

Q2: How does geopolitical risk affect Phenetron API sourcing?
A2: Trade tensions and tariffs, especially involving China and India, can disrupt supply chains, prompting companies to diversify sourcing or establish regional manufacturing partnerships.

Q3: Are there alternatives to Chinese and Indian Phenetron API suppliers?
A3: Yes, manufacturers in Europe and North America, such as BASF and Lonza, can provide specialized or high-purity APIs, though often at higher costs.

Q4: What role do contract manufacturing organizations play in Phenetron API supply?
A4: CMOs facilitate scalable synthesis, process optimization, and regulatory compliance, serving as strategic partners to ensure consistent API quality and supply.

Q5: How do quality discrepancies affect the market for Phenetron API?
A5: Variability in quality can lead to regulatory sanctions, product recalls, and loss of trust, emphasizing the importance of thorough qualification and ongoing audits of API suppliers.

References

[1] Global API Market Analysis, IQVIA, 2022.
[2] "API Manufacturing: Challenges and Opportunities," Pharmaceutical Technology, 2021.
[3] FDA Guidance on GMP Compliance, U.S. Food and Drug Administration, 2022.
[4] "Impact of Geopolitics on API Supply Chains," International Journal of Pharmaceutical Sciences, 2020.
[5] "Emerging Trends in API Production Technologies," Chemical & Engineering News, 2023.

Informed procurement and strategic partnerships in API sourcing are essential for ensuring the reliable supply of Phenetron, supporting consistent pharmaceutical manufacturing, and maintaining compliance across global markets.

Bulk Pharmaceutical API Sources for PHENETRON